Impaired BCR-mediated NF-κB signaling through the canonical pathway (p65(S529) phosphorylation and IκBα degradation), with relatively preserved TLR9-mediated NF-κB signaling, was described in the CD21low B cells of patients with CVID or with HIV infection (29). This evidence concerns the gene NFKB1 and HIV infectious disease.